Understanding CNVs in cancer can have significant clinical implications. Identifying CNVs that drive cancer can aid in the development of targeted therapies, leading to more personalized and effective treatment options. Additionally, CNVs can serve as biomarkers for cancer diagnosis, prognosis, and monitoring of treatment response. For example, detecting CNVs in circulating tumor DNA (ctDNA) can provide non-invasive insights into the cancer's genomic landscape.
